3,954
Participants
Start Date
December 1, 2017
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
LABA and the LAMA tiotropium (LABA-TIO)
combinational drug
LABA and an ICS (LABA-ICS)
combinational drug
Centre for Clinical Epidemiology, McGill University, Montreal
Lead Sponsor
Boehringer Ingelheim
INDUSTRY